Biotech Hunter
Biotech Hunter
Home
Companies
Trials
People
Search
Clinical Trials Directory
Explore 118,444 clinical trials worldwide
Search
Showing 76651-76700 of 118,444 trials
Active filters:
Status: Recruiting, Active, not recruiting, Enrolling by invitation, Not yet recruiting
Clinical Trials (118,444)
NCT06162442
Management of the Ocular Surface With Preservative-Free Lubricants in Patients With Dry Eye
N/A
Recruiting
132 participants
Started: Mar 15, 2023 · Completed: Apr 15, 2024
1 condition
1 sponsor
1 location
NCT05266807
Fecal Microbiota Transplantation in Clostridioides Difficile Infection First Episode and First Recurrence
PHASE3
Recruiting
220 participants
Started: Mar 15, 2023 · Completed: Jan 31, 2028
1 condition
1 sponsor
7 locations
NCT05803252
Videoconferencing-based Focused Acceptance and Commitment Therapy for Parents of SHCN Children
NA
Recruiting
104 participants
Started: Mar 15, 2023 · Completed: Dec 31, 2025
5 conditions
5 sponsors
5 locations
NCT06764459
Molecular Characterization of Patients With Acute Myeloid Leukemia and the Impact of Clonal Evolution in the Response to Therapeutic Treatments
N/A
Recruiting
20 participants
Started: Mar 15, 2023 · Completed: Dec 31, 2026
1 condition
1 sponsor
1 location
NCT05662397
A Study of HST-1011 Given as Monotherapy and in Combination With an Anti-PD1 Antibody
PHASE1/PHASE2
Active, not recruiting
77 participants
Started: Mar 15, 2023 · Completed: Dec 31, 2026
3 conditions
1 sponsor
14 locations
NCT05457556
Mismatched Related Donor Versus Matched Unrelated Donor Stem Cell Transplantation for Children, Adolescents, and Young Adults With Acute Leukemia or Myelodysplastic Syndrome
PHASE3
Active, not recruiting
435 participants
Started: Mar 15, 2023 · Completed: Jun 30, 2026
4 conditions
1 sponsor
63 locations
NCT05720130
Phase Ib/IIa Dose Escalation and Expansion Study of [²¹²Pb]Pb-ADVC001 in Metastatic Castration Resistant Prostate Cancer (TheraPb - Phase I/II Study).
PHASE1/PHASE2
Recruiting
100 participants
Started: Mar 15, 2023 · Completed: Dec 31, 2029
2 conditions
1 sponsor
2 locations
NCT06350760
Transdiagnostic, Indicated Preventive Intervention for Adolescents At High Risk of Emotional Problems W/Add-On Modules
NA
Recruiting
30 participants
Started: Mar 15, 2023 · Completed: Dec 31, 2025
2 conditions
4 sponsors
3 locations
NCT05481931
Non Interventional Safety Study of NUCEIVA for the Treatment of Moderate-to-Severe Glabellar Lines
N/A
Active, not recruiting
756 participants
Started: Mar 15, 2023 · Completed: Jan 31, 2026
1 condition
2 sponsors
1 location
NCT05775289
A Study of Tobemstomig Plus Platinum-Based Chemotherapy vs Pembrolizumab Plus Platinum-Based Chemotherapy in Participants With Previously Untreated Non-Small Cell Lung Cancer
PHASE2
Active, not recruiting
182 participants
Started: Mar 15, 2023 · Completed: Jun 1, 2026
1 condition
1 sponsor
50 locations
NCT05718245
HEPA, PM2.5, and Cardiometabolic Health
NA
Recruiting
52 participants
Started: Mar 15, 2023 · Completed: Dec 31, 2026
2 conditions
2 sponsors
1 location
NCT06444126
The Incidence And Risk Factors Of Recurrent Febrile Seizures And Epilepsy Following Febrile Seizures
N/A
Recruiting
650 participants
Started: Mar 15, 2023 · Completed: Sep 15, 2025
2 conditions
1 sponsor
1 location
NCT06429124
Time Restricted Eating in Alzheimer's Disease
NA
Recruiting
30 participants
Started: Mar 15, 2023 · Completed: Mar 14, 2026
1 condition
4 sponsors
2 locations
NCT05740943
Induction Lorlatinib in Stage III Non-small Cell Lung Cancer
PHASE2
Recruiting
48 participants
Started: Mar 15, 2023 · Completed: Dec 31, 2026
2 conditions
1 sponsor
1 location
NCT05734755
Dietary Programme and Exercise Training in Combination or Separately on Managing Sarcopenic Obesity in Older Adults
NA
Recruiting
380 participants
Started: Mar 15, 2023 · Completed: Mar 15, 2026
1 condition
1 sponsor
1 location
NCT05846438
Effect of Drain Care on Infection Rate and Quality of Life in Implant-Based Breast Reconstruction.
NA
Recruiting
100 participants
Started: Mar 15, 2023 · Completed: Mar 15, 2025
2 conditions
1 sponsor
1 location
NCT06992765
Evaluation of Green Tea for Improving Blood Lipid Profile
NA
Active, not recruiting
38 participants
Started: Mar 15, 2023 · Completed: Aug 30, 2025
1 condition
2 sponsors
1 location
NCT06140914
Biological Mechanisms Behind Resynchronization Therapy in Heart Failure
N/A
Recruiting
220 participants
Started: Mar 15, 2023 · Completed: Mar 31, 2026
2 conditions
1 sponsor
1 location
NCT05546879
Study Investigating the Association of NP137 With Atezolizumab-Bevacizumab Combination in First Line in Unresectable HCC
PHASE1
Recruiting
52 participants
Started: Mar 15, 2023 · Completed: Mar 15, 2027
1 condition
2 sponsors
1 location
NCT05744102
Improve MRI Diagnosis
NA
Not yet recruiting
2,016 participants
Started: Mar 15, 2023 · Completed: Mar 15, 2030
1 condition
1 sponsor
1 location
NCT05744934
Interstage Monitoring Using an Implantable Loop Recorder: A Pilot Study
EARLY_PHASE1
Recruiting
10 participants
Started: Mar 15, 2023 · Completed: Sep 10, 2027
1 condition
1 sponsor
1 location
NCT05732402
An Open-label Study of Povetacicept in Autoantibody-Associated Glomerular Diseases
PHASE1/PHASE2
Active, not recruiting
72 participants
Started: Mar 15, 2023 · Completed: Mar 2, 2028
4 conditions
1 sponsor
30 locations
NCT05908643
A First-In-Human Trial of pTTL in Advanced Colorectal Cancer
PHASE1/PHASE2
Recruiting
16 participants
Started: Mar 15, 2023 · Completed: Jun 30, 2032
1 condition
5 sponsors
2 locations
NCT05632744
Evaluation of CG-100 Intraluminal Bypass Device
NA
Recruiting
10 participants
Started: Mar 15, 2023 · Completed: Jun 15, 2024
1 condition
1 sponsor
1 location
NCT06125873
Effect of Moringa Leaf Capsules on Glycemic Control of Type 2 Diabetic Patients
PHASE2
Enrolling by invitation
50 participants
Started: Mar 15, 2023 · Completed: Aug 1, 2024
1 condition
1 sponsor
1 location
NCT06314958
Stage II/III Colorectal Cancer Recurrence
N/A
Recruiting
400 participants
Started: Mar 15, 2023 · Completed: Jun 18, 2026
5 conditions
1 sponsor
4 locations
NCT05744427
Safety and Tolerability of JSKN003 in Chinese Subjects With Advanced Solid Tumors
PHASE1/PHASE2
Active, not recruiting
725 participants
Started: Mar 15, 2023 · Completed: Dec 31, 2026
1 condition
1 sponsor
34 locations
NCT06202950
Type 1 Diabetes,Mindfulness,Yoga,Stress,Health Quality,Glycemic İndex
NA
Active, not recruiting
90 participants
Started: Mar 15, 2023 · Completed: Jul 15, 2025
2 conditions
1 sponsor
2 locations
NCT05772273
PD-1 Inhibitor, Azacitidine and Low-dose DLI in AML Relapse After Allo-HSCT
NA
Recruiting
43 participants
Started: Mar 15, 2023 · Completed: Dec 31, 2025
1 condition
2 sponsors
1 location
NCT05782387
Mucolipidosis Type IV Natural History Study
N/A
Recruiting
50 participants
Started: Mar 15, 2023 · Completed: Mar 31, 2026
1 condition
1 sponsor
1 location
NCT05687357
Tislelizumab in Combination With Pre-operative CRT Versus SOC for Locally Advanced G/GEJ Adenocarcinoma
PHASE2
Recruiting
140 participants
Started: Mar 15, 2023 · Completed: Aug 31, 2027
2 conditions
1 sponsor
3 locations
NCT05435222
Evaluation of a Male-specific Psychotherapeutic Program for Major Depressive Disorders
NA
Recruiting
244 participants
Started: Mar 15, 2023 · Completed: Oct 31, 2025
1 condition
1 sponsor
1 location
NCT05787561
A Study of Avutometinib (VS-6766) and Defactinib in People With Mesonephric Gynecologic Cancer
PHASE2
Recruiting
40 participants
Started: Mar 15, 2023 · Completed: Mar 31, 2026
1 condition
2 sponsors
7 locations
NCT05660460
COPD at a Street Level
NA
Recruiting
511 participants
Started: Mar 15, 2023 · Completed: Jan 31, 2029
1 condition
2 sponsors
1 location
NCT05752643
Feasibility and Impact of Online HIV/STI Screening Addressed to PrEP Users in Spain
NA
Not yet recruiting
218 participants
Started: Mar 15, 2023 · Completed: Dec 31, 2025
2 conditions
3 sponsors
0 locations
NCT05301140
Vivistim Registry for Paired VNS Therapy (GRASP)
N/A
Recruiting
1,000 participants
Started: Mar 15, 2023 · Completed: Dec 31, 2028
1 condition
1 sponsor
2 locations
NCT06137755
Safety and Immunogenicity of CVI-VZV-001 for Prevention of Herpes Zoster in Healthy Adults Age 50 Years and Above
PHASE1
Recruiting
32 participants
Started: Mar 15, 2023 · Completed: Mar 21, 2025
2 conditions
1 sponsor
2 locations
NCT05763004
A Clinical Study to Evaluate the Safety, Tolerability and Efficacy of IOS-1002 Administered Alone and in Combination with Pembrolizumab, a PD-1 Monoclonal Antibody in Advanced Solid Tumors
PHASE1
Recruiting
140 participants
Started: Mar 15, 2023 · Completed: May 31, 2025
1 condition
2 sponsors
5 locations
NCT05709548
Use of Indocyanine Green in Acute Cholecystitis
PHASE4
Recruiting
440 participants
Started: Mar 15, 2023 · Completed: Dec 31, 2025
2 conditions
1 sponsor
2 locations
NCT05768841
Prevalence of Mental Health Issues in Endurance Athletes.
N/A
Recruiting
500 participants
Started: Mar 15, 2023 · Completed: Sep 30, 2025
2 conditions
4 sponsors
1 location
NCT05782426
Study of Polymeric Micellar Paclitaxel, Platinum Combined With Sindilizumab Injection for Advanced Non-squamous NSCLC
PHASE2
Not yet recruiting
28 participants
Started: Mar 15, 2023 · Completed: Jan 31, 2026
1 condition
1 sponsor
2 locations
NCT06219642
Mindfulness Intervention Using Virtual Reality in Older Adults With Symptoms of Anxiety and Depression in Ecuador
NA
Recruiting
90 participants
Started: Mar 15, 2023 · Completed: Aug 15, 2024
1 condition
2 sponsors
1 location
NCT05156736
Pakistan Study of Premature Coronary Atherosclerosis in Young Adults
N/A
Recruiting
2,000 participants
Started: Mar 15, 2023 · Completed: Nov 30, 2028
4 conditions
2 sponsors
1 location
NCT06320379
Zypan Functional Dyspepsia
NA
Recruiting
64 participants
Started: Mar 15, 2023 · Completed: Dec 31, 2024
1 condition
1 sponsor
1 location
NCT05848609
Functional Status and Quality of Life in Older Patients Undergoing Robotic Surgery for Colorectal Cancer
NA
Recruiting
120 participants
Started: Mar 15, 2023 · Completed: Dec 31, 2026
3 conditions
1 sponsor
2 locations
NCT06318858
Daily and Weekly Iron Supplementation in Infants
NA
Recruiting
300 participants
Started: Mar 15, 2023 · Completed: Oct 14, 2024
4 conditions
2 sponsors
1 location
NCT05482893
Spevatamig (PT886) as Monotherapy or in Combination With Chemo and/or ICI, for the Treatment of Patients With Advanced Gastric, Gastroesophageal Junction, Pancreatic Ductal or Biliary Tract Carcinomas (the TWINPEAK Study)
PHASE1/PHASE2
Recruiting
258 participants
Started: Mar 15, 2023 · Completed: Apr 30, 2028
3 conditions
2 sponsors
11 locations
NCT05310591
Combination of an Anti-PD1 Antibody With Tisagenlecleucel Reinfusion in Children, Adolescents and Young Adults With Acute Lymphoblastic Leukemia After Loss of Persistence
PHASE1/PHASE2
Recruiting
26 participants
Started: Mar 15, 2023 · Completed: Mar 31, 2027
2 conditions
1 sponsor
13 locations
NCT05212454
Efficacy of Supplement Adjuvant Capecitabine in HR+/HER2- Breast Cancer Patients With High Risks
PHASE3
Recruiting
400 participants
Started: Mar 15, 2023 · Completed: Dec 31, 2029
2 conditions
1 sponsor
1 location
NCT05423158
Virtual Care Strategies to Improve Participation in Cardiac Rehabilitation Among Veterans
PHASE2
Recruiting
150 participants
Started: Mar 15, 2023 · Completed: Feb 28, 2026
1 condition
5 sponsors
2 locations
Previous
1
More pages
1531
1532
1533
1534
1535
1536
1537
More pages
2369
Next